Positive p53 and Ki-67 markers (positive staining in >10% cells), in addition to high serum AFP levels, have been suggested as predictors of poor clinical outcomes and earlier recurrence of HCC [14]. This evidence concerns the gene TP53 and hepatocellular carcinoma.